BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27914169)

  • 1. Crystal structure of cGMP-dependent protein kinase Iβ cyclic nucleotide-binding-B domain : Rp-cGMPS complex reveals an apo-like, inactive conformation.
    Campbell JC; VanSchouwen B; Lorenz R; Sankaran B; Herberg FW; Melacini G; Kim C
    FEBS Lett; 2017 Jan; 591(1):221-230. PubMed ID: 27914169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Characterization of 8-Nitroguanosine 3',5'-Cyclic Monophosphorothioate Rp-Isomer as a Potent Inhibitor of Protein Kinase G1α.
    Ahmed KA; Zhang T; Ono K; Tsutsuki H; Ida T; Akashi S; Miyata K; Oike Y; Akaike T; Sawa T
    Biol Pharm Bull; 2017 Mar; 40(3):365-374. PubMed ID: 27980245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Analog Specificity in PKG I and II.
    Campbell JC; Henning P; Franz E; Sankaran B; Herberg FW; Kim C
    ACS Chem Biol; 2017 Sep; 12(9):2388-2398. PubMed ID: 28793191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structure of PKG I:cGMP Complex Reveals a cGMP-Mediated Dimeric Interface that Facilitates cGMP-Induced Activation.
    Kim JJ; Lorenz R; Arold ST; Reger AS; Sankaran B; Casteel DE; Herberg FW; Kim C
    Structure; 2016 May; 24(5):710-720. PubMed ID: 27066748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for cyclic-nucleotide selectivity and cGMP-selective activation of PKG I.
    Huang GY; Kim JJ; Reger AS; Lorenz R; Moon EW; Zhao C; Casteel DE; Bertinetti D; Vanschouwen B; Selvaratnam R; Pflugrath JW; Sankaran B; Melacini G; Herberg FW; Kim C
    Structure; 2014 Jan; 22(1):116-24. PubMed ID: 24239458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations of PKA cyclic nucleotide-binding domains reveal novel aspects of cyclic nucleotide selectivity.
    Lorenz R; Moon EW; Kim JJ; Schmidt SH; Sankaran B; Pavlidis IV; Kim C; Herberg FW
    Biochem J; 2017 Jul; 474(14):2389-2403. PubMed ID: 28583991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-crystal structures of PKG Iβ (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding.
    Kim JJ; Casteel DE; Huang G; Kwon TH; Ren RK; Zwart P; Headd JJ; Brown NG; Chow DC; Palzkill T; Kim C
    PLoS One; 2011 Apr; 6(4):e18413. PubMed ID: 21526164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3',5'-monophosphorothioates.
    Butt E; van Bemmelen M; Fischer L; Walter U; Jastorff B
    FEBS Lett; 1990 Apr; 263(1):47-50. PubMed ID: 2158906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cGMP analogues and protein kinase G blocker on secretory activity, apoptosis and the cAMP/protein kinase A system in porcine ovarian granulosa cells in vitro.
    Sirotkin AV; Makarevich AV; Pivko J; Kotwica J; Genieser H; Bulla J
    J Steroid Biochem Mol Biol; 2000 Sep; 74(1-2):1-9. PubMed ID: 11074350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutron Crystallography Detects Differences in Protein Dynamics: Structure of the PKG II Cyclic Nucleotide Binding Domain in Complex with an Activator.
    Gerlits O; Campbell JC; Blakeley MP; Kim C; Kovalevsky A
    Biochemistry; 2018 Mar; 57(12):1833-1837. PubMed ID: 29517905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP analog blocks kinase activation by stabilizing inactive conformation: conformational selection highlights a new concept in allosteric inhibitor design.
    Badireddy S; Yunfeng G; Ritchie M; Akamine P; Wu J; Kim CW; Taylor SS; Qingsong L; Swaminathan K; Anand GS
    Mol Cell Proteomics; 2011 Mar; 10(3):M110.004390. PubMed ID: 21081668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).
    VanSchouwen B; Selvaratnam R; Giri R; Lorenz R; Herberg FW; Kim C; Melacini G
    J Biol Chem; 2015 Nov; 290(48):28631-41. PubMed ID: 26370085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An N-terminally truncated form of cyclic GMP-dependent protein kinase Iα (PKG Iα) is monomeric and autoinhibited and provides a model for activation.
    Moon TM; Sheehe JL; Nukareddy P; Nausch LW; Wohlfahrt J; Matthews DE; Blumenthal DK; Dostmann WR
    J Biol Chem; 2018 May; 293(21):7916-7929. PubMed ID: 29602907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutron diffraction reveals hydrogen bonds critical for cGMP-selective activation: insights for cGMP-dependent protein kinase agonist design.
    Huang GY; Gerlits OO; Blakeley MP; Sankaran B; Kovalevsky AY; Kim C
    Biochemistry; 2014 Nov; 53(43):6725-7. PubMed ID: 25271401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
    Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
    Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated regulatory domains of cGMP-dependent protein kinase Ialpha and Ibeta retain dimerization and native cGMP-binding properties and undergo isoform-specific conformational changes.
    Richie-Jannetta R; Busch JL; Higgins KA; Corbin JD; Francis SH
    J Biol Chem; 2006 Mar; 281(11):6977-84. PubMed ID: 16407222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis of Cyclic Nucleotide Selectivity in cGMP-dependent Protein Kinase II.
    Campbell JC; Kim JJ; Li KY; Huang GY; Reger AS; Matsuda S; Sankaran B; Link TM; Yuasa K; Ladbury JE; Casteel DE; Kim C
    J Biol Chem; 2016 Mar; 291(11):5623-5633. PubMed ID: 26769964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclic guanosine 5'-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulation.
    Schmidtko A; Ruth P; Geisslinger G; Tegeder I
    Nitric Oxide; 2003 Mar; 8(2):89-94. PubMed ID: 12620371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
    Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
    Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.